Lilly to buy Versanis for up to $1.93 bln to boost obesity drug portfolio
July 14 (Reuters) – Eli Lilly and Co (LLY.N) said on Friday it will buy privately held Versanis for potentially up to $1.93 billion to strengthen its position in the fast-growing market for weight-loss treatments.Shares of Eli Lilly rose 3% after the deal that gives it access to an experimental obesity drug being tested along… […]